Evidence map›Paper›PMID 35892395›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Antimicrobial Activities of Secondary Metabolites from Model Mosses.

Lia R Valeeva, Ashley L Dague, Mitchell H Hall, Anastasia E Tikhonova, Margarita R Sharipova, Monica A Valentovic, Lydia M Bogomolnaya, Eugene V Shakirov

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Antimicrobial Natural Products.Antibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lia R ValeevaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
Ashley L DagueDepartment of Biological Sciences, College of Science, Marshall University, Huntington, WV 25701, USA.ORCID 0000-0002-1710-6253
Mitchell H HallDepartment of Biological Sciences, College of Science, Marshall University, Huntington, WV 25701, USA.
Anastasia E TikhonovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
Margarita R SharipovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia.
Monica A ValentovicDepartment of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.ORCID 0000-0001-7065-5721
Lydia M BogomolnayaDepartment of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
Eugene V ShakirovDepartment of Biological Sciences, College of Science, Marshall University, Huntington, WV 25701, USA.ORCID 0000-0003-2689-7410
Marshall University · USKazan Federal University · RU

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Travis Salisbury · 2012 to 2026
$61.1M
WVU &MU NEW FACULTY GRANTSP20RR016477 · NCRR · MARSHALL UNIVERSITY · PI RANKIN, GARY O · 2001 to 2011
$35.5M
Capsaicin and Small cell Lung Cancer TherapyR15CA161491 · NCI · MARSHALL UNIVERSITY · PI DASGUPTA, PIYALI · 2012 to 2021
$1.3M
Thymidine Phosphorylase: a Novel Target of Antiplatelet TherapyR15HL145573 · NHLBI · MARSHALL UNIVERSITY · PI LI, WEI · 2019 to 2022
$878k
NCI NIH HHS R15 CA161491NCRR NIH HHS P20 RR016477NHLBI NIH HHS R15 HL145573NIGMS NIH HHS P20 GM103434
6 · The paper itself

Abstract

Plants synthetize a large spectrum of secondary metabolites with substantial structural and functional diversity, making them a rich reservoir of new biologically active compounds. Among different plant lineages, the evolutionarily ancient branch of non-vascular plants (Bryophytes) is of particular interest as these organisms produce many unique biologically active compounds with highly promising antibacterial properties. Here, we characterized antibacterial activity of metabolites produced by different ecotypes (strains) of the model mosses Physcomitrium patens and Sphagnum fallax. Ethanol and hexane moss extracts harbor moderate but unstable antibacterial activity, representing polar and non-polar intracellular moss metabolites, respectively. In contrast, high antibacterial activity that was relatively stable was detected in soluble exudate fractions of P. patens moss. Antibacterial activity levels in P. patens exudates significantly increased over four weeks of moss cultivation in liquid culture. Interestingly, secreted moss metabolites are only active against a number of Gram-positive, but not Gram-negative, bacteria. Size fractionation, thermostability and sensitivity to proteinase K assays indicated that the secreted bioactive compounds are relatively small (less than <10 kDa). Further analysis and molecular identification of antibacterial exudate components, combined with bioinformatic analysis of model moss genomes, will be instrumental in the identification of specific genes involved in the bioactive metabolite biosynthesis.

Indexed as

antibacterial activityBryophytesextractexudatemossPhyscomitrium patensplant metaboliteSphagnum fallax

Identifiers

PMID35892395
PMCPMC9331938
OpenAlexW4288039911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.